Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Cyclophosphamide × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 491 Triple Negative Breast Neoplasms 77 Inflammatory Breast Neoplasms 29 Breast Neoplasms, Male 26 Neoplasm Metastasis 23 Ovarian Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Melanoma 20 Neoplasms 14 Pancreatic Neoplasms 13 Colorectal Neoplasms 12 Carcinoma, Renal Cell 11 Stomach Neoplasms 10 Multiple Myeloma 10 Lung Neoplasms 9 Carcinoma, Ovarian Epithelial 9 Lymphoma, Non-Hodgkin 8 Carcinoma, Hepatocellular 8 Sarcoma 7 Lymphoma, Follicular 7 Lymphoma 7 Recurrence 6 Neutropenia 6 Lymphoma, Mantle-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Myeloid, Acute 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Kidney Neoplasms 6

Interventions

Trastuzumab 29 pyrotinib 15 pertuzumab 15 Docetaxel 13 Paclitaxel 7 Capecitabine 6 tucatinib 5 Carboplatin 4 neratinib 3 Ado-Trastuzumab Emtansine 3 trastuzumab deruxtecan 2 atezolizumab 2 Protons 2 Fulvestrant 2 pegfilgrastim 1 palbociclib 1 margetuximab 1 liposomal doxorubicin 1 inavolisib 1 exemestane 1 envafolimab 1 dalpiciclib 1 Taxoids 1 Neoadjuvant Therapy 1 Metformin 1 Leuprolide 1 Letrozole 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Hospital Information Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02379585 2018-04-24

STEFNE

Western Regional Medical Center

Phase 1/2 Terminated

8 enrolled 1 chart

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡